Trial in HPV Prevention for the U.S. Vietnamese Community
HERO
Applying the Multiphase Optimization Strategy to Develop and Test a Culturally-Relevant Digital Health Intervention Targeting HPV Vaccination Among U.S. Vietnamese
2 other identifiers
interventional
96
1 country
1
Brief Summary
The purpose of the HERO study is to leverage the Multiphase Optimization Strategy (MOST) framework to conduct a pilot trial testing four different intervention components (expert video, self-persuasion, narrative storytelling, and motivational interviewing) targeting HPV vaccination among U.S. Vietnamese. PRIMARY AIM To assess the feasibility and acceptability of each of the four digital HERO intervention components in a pilot optimization trial using the MOST framework. Using a highly efficient design, the study team will randomize 96 Vietnamese parents of unvaccinated adolescents to receive 0 to 4 HERO components. The study team will establish the feasibility (reach, retention, adherence) and acceptability (usability, satisfaction, usefulness, cultural relevance) of each component (expert video, self-persuasion, narrative storytelling, and motivational interviewing). SECONDARY AIM To investigate effects of each component on HPV vaccination outcomes and psychosocial mediators. The study team will examine the effects on HPV vaccination (initiation and intention) and psychosocial mediators.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2026
CompletedFirst Submitted
Initial submission to the registry
May 26, 2026
CompletedFirst Posted
Study publicly available on registry
June 10, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2029
June 11, 2026
June 1, 2026
3.2 years
May 26, 2026
June 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Feasibility: Reach
Number of enrolled participants divided by number of eligible individuals
Baseline
Feasibility: Retention
Number of of participants who drop out divided by number of randomized participants
1, 3, and 6 months post-randomization
Feasibility: Adherence
Self-persuasion task: number of web launches and length of time spent completing task; Expert video and narrative storytelling: number of views and length of engagement time; Motivational interviewing: number of completed motivational interviewing calls and length of each call
1-month post randomization
Acceptability
Survey questions and semi-structured interviews exploring cultural relevance; reason for use/lack of use; aspects participants liked the most/least; ideas for improvement
1-month post randomization
Secondary Outcomes (4)
HPV vaccine initiation (adolescents)
1, 3 and 6 months post-randomization
HPV vaccine intention
Baseline, 1-month, 3-month, and 6-month post-randomization
Beliefs, attitudes, and trust in HPV vaccine
Baseline, 1-month, 3-month, and 6-month post randomization
Beliefs, attitudes, and trust in other childhood/adolescent vaccines
Baseline, 1-month, 3-month, and 6-month post randomization
Study Arms (16)
Experimental: Exp Condition 1
EXPERIMENTALResearch participant receives the Constant component + Expert video + Self-persuasion + Narrative storytelling + Motivational interviewing
Experimental: Exp Condition 2
EXPERIMENTALResearch participant receives Constant + Expert video + Self-persuasion + Narrative storytelling.
Experimental: Exp Condition 3
EXPERIMENTALResearch participant receives Constant + Expert video + Self-persuasion + Motivational interviewing
Experimental: Exp Condition 4
EXPERIMENTALResearch participant receives Constant + Expert video + Self-persuasion
Experimental: Exp Condition 5
EXPERIMENTALResearch participant receives Constant + Expert video + Narrative storytelling + Motivational interviewing
Experimental: Exp Condition 6
EXPERIMENTALResearch participant receives Constant + Expert video + Narrative storytelling
Experimental: Exp Condition 7
EXPERIMENTALResearch participant receives Constant + Expert video + Motivational interviewing
Experimental: Exp Condition 8
EXPERIMENTALResearch participant receives Constant + Expert video
Experimental: Exp Condition 9
EXPERIMENTALResearch participant receives Constant + Self-persuasion + Narrative storytelling + Motivational interviewing
Experimental: Exp Condition 10
EXPERIMENTALResearch participant receives Constant + Self-persuasion + Narrative storytelling
Experimental: Exp Condition 11
EXPERIMENTALResearch participant receives Constant + Self-persuasion + Motivational interviewing
Experimental: Exp Condition 12
EXPERIMENTALResearch participant receives Constant + Self-persuasion
Experimental: Exp Condition 13
EXPERIMENTALResearch participant receives Constant + Narrative storytelling + Motivational interviewing
Experimental: Exp Condition 14
EXPERIMENTALResearch participant receives Constant + Narrative storytelling
Experimental: Exp Condition 15
EXPERIMENTALResearch participant receives Constant + Motivational interviewing
Experimental: Exp Condition 16
EXPERIMENTALResearch participant receives the Constant component only
Interventions
Participants will watch a video featuring Vietnamese healthcare providers. In the video, the providers will endorse vaccine safety and efficacy, dispel common misconceptions or concerns, and use verbal persuasion techniques to recommend HPV vaccination.
Participants will complete an interactive web-based task where they audio record reasons, summarized in their own words, for getting their adolescent the HPV vaccine.
Participants will watch a video featuring U.S. Vietnamese parents. In the video, featured parents will describe stories of their experiences learning about the HPV vaccine as well as motivations to initiate and complete the vaccine series on-time for their adolescents.
Participants will receive 2 calls (phone or Zoom) from a trained U.S. Vietnamese health educator. The health educator will use motivation interviewing (e.g., open-ended questions, acknowledging feelings, affirmations, reflective listening) to increase opportunities for and commitment to HPV vaccination while decreasing barriers (e.g., safety or access concerns).
Each participant will receive the constant component through the study website, which includes a vaccine information statement from the CDC with details on HPV vaccine benefits, potential side effects, and recommended vaccination schedule, as well as online information on access and locations for HPV vaccine (e.g., list of Vaccines for Children providers where Medicaid, uninsured, or underinsured adolescents can be vaccinated for free).
Eligibility Criteria
You may qualify if:
- Self-identify as U.S. Vietnamese.
- Are the parent of a youth ages 9-18 who have not initiated the HPV vaccine series. Only one parent per household will be able to participate.
- Have lived in the U.S. for 12 months or more.
You may not qualify if:
- Planning to move out of the U.S. within the next 6 months.
- Not fluent in either spoken and written Vietnamese or spoken and written English.
- Inability to provide informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwestern Universitylead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Northwestern University
Chicago, Illinois, 60611, United States
Related Publications (27)
Collins LM, Murphy SA, Strecher V. The multiphase optimization strategy (MOST) and the sequential multiple assignment randomized trial (SMART): new methods for more potent eHealth interventions. Am J Prev Med. 2007 May;32(5 Suppl):S112-8. doi: 10.1016/j.amepre.2007.01.022.
PMID: 17466815BACKGROUNDKim M, Lee H, Kiang P, Allison J. Development and acceptability of a peer-paired, cross-cultural and cross-generational storytelling HPV intervention for Korean American college women. Health Educ Res. 2019 Oct 1;34(5):483-494. doi: 10.1093/her/cyz022.
PMID: 31298268BACKGROUNDWyrick DL, Rulison KL, Fearnow-Kenney M, Milroy JJ, Collins LM. Moving beyond the treatment package approach to developing behavioral interventions: addressing questions that arose during an application of the Multiphase Optimization Strategy (MOST). Transl Behav Med. 2014 Sep;4(3):252-9. doi: 10.1007/s13142-013-0247-7.
PMID: 25264465BACKGROUNDVu M, Berg CJ, Pham NT, Tiro JA, Escoffery C, Spring B, Bednarczyk RA, Ta D, Kandula NR. U.S. Vietnamese parents' trusted sources of information and preferences for intervention messaging about HPV vaccination: A mixed methods study. PEC Innov. 2023 Jul 6;3:100189. doi: 10.1016/j.pecinn.2023.100189. eCollection 2023 Dec 15.
PMID: 37521956BACKGROUNDJin H, Pinheiro PS, Xu J, Amei A. Cancer incidence among Asian American populations in the United States, 2009-2011. Int J Cancer. 2016 May 1;138(9):2136-45. doi: 10.1002/ijc.29958. Epub 2016 Jan 29.
PMID: 26661680BACKGROUNDVu M, Huynh VN, Bednarczyk RA, Escoffery C, Ta D, Nguyen TT, Berg CJ. Experience and lessons learned from multi-modal internet-based recruitment of U.S. Vietnamese into research. PLoS One. 2021 Aug 13;16(8):e0256074. doi: 10.1371/journal.pone.0256074. eCollection 2021.
PMID: 34388178BACKGROUNDNational Cancer Institute. Future Directions - Division of Cancer Control & Population Sciences. Published 2023. Accessed January 12, 2024. https://cancercontrol.cancer.gov/research-emphasis/future-directions
BACKGROUNDNational Cancer Institute. Cancer Health Disparities Research. Published 2021. Accessed September 29, 2022. https://www.cancer.gov/research/areas/disparities
BACKGROUNDNational Cancer Institute. Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population Sciences. Published 2023. https://grants.nih.gov/grants/guide/notice-files/NOTCA- 24-022.html
BACKGROUNDAarons GA, Sklar M, Mustanski B, Benbow N, Brown CH. "Scaling-out" evidence-based interventions to new populations or new health care delivery systems. Implement Sci. 2017 Sep 6;12(1):111. doi: 10.1186/s13012-017-0640-6.
PMID: 28877746BACKGROUNDCollins LM. Optimization of Behavioral, Biobehavioral, and Biomedical Interventions. Springer International Publishing; 2018. doi:10.1007/978-3-319-72206-1
BACKGROUNDLee HY, Koopmeiners JS, McHugh J, Raveis VH, Ahluwalia JS. mHealth Pilot Study: Text Messaging Intervention to Promote HPV Vaccination. Am J Health Behav. 2016 Jan;40(1):67-76. doi: 10.5993/AJHB.40.1.8.
PMID: 26685815BACKGROUNDMa GX, Zhu L, Tan Y, Zhai S, Lin TR, Zambrano C, Siu P, Lai S, Wang MQ. A Multilevel Intervention to Increase HPV Vaccination among Asian American Adolescents. J Community Health. 2022 Feb;47(1):9-16. doi: 10.1007/s10900-021-01013-z. Epub 2021 Jul 7.
PMID: 34232452BACKGROUNDChen AC, Kim WS, Todd M, Larkey L. A Digital Storytelling Intervention for Vietnamese American Mothers to Promote Their Children's HPV Vaccination. Cancer Prev Res (Phila). 2022 Jul 5;15(7):465-472. doi: 10.1158/1940-6207.CAPR-21-0618.
PMID: 35314854BACKGROUNDLee H, Kim M, Cooley ME, Kiang PN, Kim D, Tang S, Shi L, Thiem L, Kan P, Peou S, Touch C, Chea P, Allison J. Using narrative intervention for HPV vaccine behavior change among Khmer mothers and daughters: A pilot RCT to examine feasibility, acceptability, and preliminary effectiveness. Appl Nurs Res. 2018 Apr;40:51-60. doi: 10.1016/j.apnr.2017.12.008. Epub 2017 Dec 18.
PMID: 29579499BACKGROUNDKim M, Lee H, Kiang P, Aronowitz T, Sheldon LK, Shi L, Allison JJ. A Storytelling Intervention in a Mobile, Web-Based Platform: A Pilot Randomized Controlled Trial to Evaluate the Preliminary Effectiveness to Promote Human Papillomavirus Vaccination in Korean American College Women. Health Educ Behav. 2020 Apr;47(2):258-263. doi: 10.1177/1090198119894589. Epub 2020 Jan 20.
PMID: 31958991BACKGROUNDLee G, Chang A, Pal A, Tran TA, Cui X, Quach T. Understanding and Addressing the Digital Health Literacy Needs of Low-Income Limited English Proficient Asian American Patients. Health Equity. 2022 Jul 4;6(1):494-499. doi: 10.1089/heq.2022.0045. eCollection 2022.
PMID: 36186613BACKGROUNDAdia AC, Nazareno J, Operario D, Ponce NA. Health Conditions, Outcomes, and Service Access Among Filipino, Vietnamese, Chinese, Japanese, and Korean Adults in California, 2011-2017. Am J Public Health. 2020 Apr;110(4):520-526. doi: 10.2105/AJPH.2019.305523. Epub 2020 Feb 20.
PMID: 32078359BACKGROUNDHopfer S, Dyda A, Brandt HM. Editorial: Digital solutions to HPV vaccination. Front Digit Health. 2022 Aug 9;4:972234. doi: 10.3389/fdgth.2022.972234. eCollection 2022. No abstract available.
PMID: 36743721BACKGROUNDVu M, Ta D, Berg CJ, Bednarczyk RA, Huynh VN, King AR, Escoffery C. U.S. Vietnamese Mothers' HPV Vaccine Decision-Making for Their Adolescents: A Qualitative Study. J Health Care Poor Underserved. 2022;33(4):1985-2006. doi: 10.1353/hpu.2022.0149.
PMID: 36341674BACKGROUNDZimet GD, Silverman RD, Bednarczyk RA, English A. Adolescent Consent for Human Papillomavirus Vaccine: Ethical, Legal, and Practical Considerations. J Pediatr. 2021 Apr;231:24-30. doi: 10.1016/j.jpeds.2021.01.026. Epub 2021 Jan 20.
PMID: 33484694BACKGROUNDFalcaro M, Castanon A, Ndlela B, Checchi M, Soldan K, Lopez-Bernal J, Elliss-Brookes L, Sasieni P. The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study. Lancet. 2021 Dec 4;398(10316):2084-2092. doi: 10.1016/S0140-6736(21)02178-4. Epub 2021 Nov 3.
PMID: 34741816BACKGROUNDPedersen C, Petaja T, Strauss G, Rumke HC, Poder A, Richardus JH, Spiessens B, Descamps D, Hardt K, Lehtinen M, Dubin G; HPV Vaccine Adolescent Study Investigators Network. Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant. J Adolesc Health. 2007 Jun;40(6):564-71. doi: 10.1016/j.jadohealth.2007.02.015.
PMID: 17531764BACKGROUNDCenters for Disease Control and Prevention. HPV Vaccine Recommendations. Published 2021. Accessed May 4, 2022. https://www.cdc.gov/vaccines/vpd/hpv/hcp/recommendations.html
BACKGROUNDPingali C, Yankey D, Elam-Evans LD, Trahan A, Markowitz LE, DeSisto CL, Hughes M, Valier MR, Stokley S, Singleton JA. Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2024. MMWR Morb Mortal Wkly Rep. 2025 Aug 14;74(30):466-472. doi: 10.15585/mmwr.mm7430a1.
PMID: 40811113BACKGROUNDVu M, Bednarczyk RA, Escoffery C, Ta D, Huynh VN, Berg CJ. U.S. Vietnamese parents' HPV vaccine decision-making for their adolescents: an exploration of practice-, provider-, and patient-level influences. J Behav Med. 2022 Apr;45(2):197-210. doi: 10.1007/s10865-021-00265-3. Epub 2021 Nov 18.
PMID: 34792723BACKGROUNDUnited States Census Bureau. 2021 American Community Survey 1-Year Estimates Total Population, Vietnamese Alone or in Any Combination. Published 2021. Accessed September 28, 2022. http://data.census.gov
BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Milkie Vu, PhD
Northwestern University
- STUDY DIRECTOR
Namratha Kandula
Northwestern University
- STUDY DIRECTOR
Siobhan Phillips
Northwestern University
- STUDY DIRECTOR
Juned Siddique
Northwestern University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 26, 2026
First Posted
June 10, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
June 30, 2029
Study Completion (Estimated)
June 30, 2029
Last Updated
June 11, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to the risk of re-identification. We want to protect participant confidentiality.